Successful administration of glecaprevir/pibrentasvir via percutaneous endoscopic gastrostomy in a pediatric patient with chronic hepatitis C and spinal muscular atrophy receiving risdiplam
Clinical Journal of Gastroenterology · 18.08.2026
DOI: 10.1007/s12328-026-02427-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of Gastroenterology, online erschienen am 18.08.2026. Verfasst von Marta Carfagna und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Infectious Disease Unit, Salesi Children Hospital, Azienda Ospedaliero Universitaria delle Marche, Via F. Corridoni 11, 60123, Ancona, Ital…. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Glecaprevir/Pibrentasvir (GLE/PIB) is an interferon-free direct-acting antiviral (DAA) regimen indicated for the treatment of chronic hepatitis C virus (HCV) infection. However, data on the pharmacokinetics and stability of crushed or split tablets are lacking, complicating administration in patients with dysphagia requiring percutaneous endoscopic gastrostomy (PEG). Additionally, no published studies have evaluated the safety and efficacy of DAAs in combination with Risdiplam, the first oral therapy developed for spinal muscular atrophy (SMA). We report a case of a 14-year-old dysphagic patient with SMA, receiving Risdiplam, who was successfully treated with crushed GLE/PIB administrated via PEG. The patient achieved a sustained virologic response (SVR) 12 weeks after the end of therapy, without significant adverse effects, and no drug interactions were observed during the course of treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Infectious Disease Unit, Salesi Children Hospital, Azienda Ospedaliero Universitaria delle Marche, Via F. Corridoni 11, 60123, Ancona, Italy. marta.carfagna@ospedaliriuniti.marche.it.
- Department of Pediatrics, Polytechnic University of Marche, Ancona, Italy.
- Pediatric Infectious Disease Unit, Salesi Children Hospital, Azienda Ospedaliero Universitaria delle Marche, Via F. Corridoni 11, 60123, Ancona, Italy.
- Hospital Pharmacy, Salesi Children Hospital, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy.
- Department of Radiological Sciences, Salesi Children Hospital, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy.
Zitieren
APA
Carfagna, M., Carciofi, A., Palpacelli, A., Andresciani, E., Garzone, A. M. F., Pieroni, G., Campioni, D., & Zallocco, F. (2026). Successful administration of glecaprevir/pibrentasvir via percutaneous endoscopic gastrostomy in a pediatric patient with chronic hepatitis C and spinal muscular atrophy receiving risdiplam. Clinical Journal of Gastroenterology. https://doi.org/10.1007/s12328-026-02427-9
Vancouver
Carfagna M, Carciofi A, Palpacelli A, Andresciani E, Garzone AMF, Pieroni G, et al. Successful administration of glecaprevir/pibrentasvir via percutaneous endoscopic gastrostomy in a pediatric patient with chronic hepatitis C and spinal muscular atrophy receiving risdiplam. Clinical Journal of Gastroenterology. 2026. doi:10.1007/s12328-026-02427-9
BibTeX
@article{Carfagna2026,
author = {Carfagna, Marta and Carciofi, Annalisa and Palpacelli, Alessandra and Andresciani, Emanuela and Garzone, Angela Maria Felicita and Pieroni, Giovanni and Campioni, Daniele and Zallocco, Federica},
title = {Successful administration of glecaprevir/pibrentasvir via percutaneous endoscopic gastrostomy in a pediatric patient with chronic hepatitis C and spinal muscular atrophy receiving risdiplam},
journal = {Clinical Journal of Gastroenterology},
year = {2026},
doi = {10.1007/s12328-026-02427-9}
}
EUVIMED